AI designs drugs for untreatable diseases

AI re-engineers language models to design drugs for previously untreatable diseases. A new AI tool, PepMLM, designs molecules targeting harmful proteins using only their amino acid sequences, bypassing the need for structural data. This breakthrough could lead to treatments for cancers, brain disorders, and viral infections. The AI was developed by researchers from McMaster, Duke, and Cornell universities, building on language model technology. Lab tests show the designed peptides can bind to and break down disease-related proteins.